· 'Restless leg syndrome can ruin people's lives'
· British drug firms' figures outstrip expectations
Friday April 28, 2006
Studies published in a respected medical journal, the Public Library of Science Medicine, this month accused the big pharmaceutical companies of "medicalising" problems such as high cholesterol and sexual dysfunction. The authors of the report highlighted the "restless legs" syndrome, described by GSK as "common yet unrecognised" when it launched its Ropinirole treatment last year.